523
+3.36%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥57.82bn
FY2017FY2026
Net income
¥4.57bn
FY2017FY2026
Free cash flow
¥1.02bn
FY2017FY2026
Shareholders' equity
¥29.28bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥57.82bn | ¥56.18bn | ¥46.26bn | ¥48.80bn | ¥41.97bn | ¥32.57bn | ¥33.00bn | ¥32.18bn | ¥28.89bn | ¥22.76bn |
| Gross profit | ¥20.45bn | ¥20.01bn | ¥15.40bn | ¥16.91bn | ¥14.66bn | ¥11.29bn | ¥14.42bn | ¥14.65bn | ¥13.70bn | ¥10.03bn |
| Research and development | — | ¥1.50bn | — | — | — | — | — | — | — | — |
| Operating income | ¥4.76bn | ¥4.87bn | ¥882.6m | ¥3.39bn | ¥5.18bn | ¥509.3m | ¥2.71bn | ¥3.06bn | ¥2.93bn | ¥306.5m |
| Net income | ¥4.57bn | ¥3.42bn | ¥804.8m | ¥2.05bn | ¥3.51bn | −¥285.0m | ¥1.55bn | ¥1.80bn | ¥1.64bn | ¥74.3m |
| Diluted earnings per share | 33.43 | 24.90 | 5.89 | 14.34 | 23.60 | -2.21 | 12.01 | 13.26 | 11.99 | 0.54 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥61.64bn | ¥49.80bn | ¥50.61bn | ¥46.34bn | ¥43.72bn | ¥37.52bn | ¥34.52bn | ¥24.14bn | ¥18.23bn | ¥11.76bn |
| Cash and short-term investments | ¥29.00bn | ¥25.04bn | ¥25.81bn | ¥26.11bn | ¥26.61bn | ¥24.46bn | ¥21.90bn | ¥13.85bn | ¥8.38bn | ¥4.74bn |
| Total liabilities | ¥31.92bn | ¥24.58bn | ¥27.33bn | ¥23.94bn | ¥27.53bn | ¥23.62bn | ¥20.65bn | ¥12.23bn | ¥11.31bn | ¥6.71bn |
| Debt | ¥18.85bn | ¥11.81bn | ¥15.44bn | ¥13.57bn | ¥16.64bn | ¥17.91bn | ¥14.00bn | ¥4.86bn | ¥3.54bn | ¥2.54bn |
| Shareholders' equity | ¥29.28bn | ¥24.19bn | ¥22.40bn | ¥21.74bn | ¥15.58bn | ¥13.24bn | ¥13.22bn | ¥11.31bn | ¥6.28bn | ¥4.66bn |
| Shares outstanding | 137m | 137m | 137m | 143m | 149m | 129m | 129m | 136m | 137m | 137m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥2.07bn | ¥5.82bn | −¥362.7m | ¥1.98bn | ¥6.87bn | −¥1.52bn | ¥736.9m | ¥2.17bn | ¥3.26bn | −¥970.4m |
| Capital spending | −¥1.04bn | −¥509.4m | −¥770.0m | −¥5.7m | −¥2.08bn | −¥384.0m | −¥17.7m | −¥267.0m | −¥267.0m | −¥267.0m |
| Free cash flow | ¥1.02bn | ¥5.31bn | −¥1.13bn | ¥1.98bn | ¥4.78bn | −¥1.91bn | ¥719.2m | ¥1.90bn | ¥3.00bn | −¥1.24bn |
| Dividends paid | −¥304.7m | −¥315.1m | −¥320.9m | −¥290.8m | −¥80.0m | −¥290.0m | −¥11.80bn | — | — | — |
Latest quarters
By quarter end
| Apr 2026 | Jan 2026 | Dec 2025 | Oct 2025 | Sept 2025 | Jul 2025 | Jun 2025 | Apr 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥15.47bn | ¥14.52bn | ¥14.07bn | ¥14.07bn | ¥13.77bn | ¥13.77bn | ¥16.80bn | ¥16.80bn |
| Gross profit | ¥5.18bn | ¥5.04bn | ¥5.01bn | ¥5.01bn | ¥5.22bn | ¥5.22bn | ¥6.46bn | ¥6.46bn |
| Operating income | ¥756.5m | ¥1.09bn | ¥1.24bn | ¥1.24bn | ¥1.67bn | ¥1.67bn | ¥1.99bn | ¥1.99bn |
| Net income | ¥968.2m | ¥1.02bn | ¥913.7m | ¥913.7m | ¥1.66bn | ¥1.66bn | ¥1.72bn | ¥1.72bn |
| Diluted earnings per share | 7.09 | 7.47 | 6.65 | 6.65 | 12.08 | 12.12 | 12.34 | 12.56 |
| Total assets | ¥61.64bn | ¥50.41bn | ¥50.74bn | ¥50.74bn | ¥47.97bn | ¥47.97bn | ¥49.80bn | ¥49.80bn |
| Cash and short-term investments | ¥29.00bn | ¥19.30bn | ¥23.40bn | ¥23.40bn | ¥22.04bn | ¥22.04bn | ¥25.04bn | ¥25.04bn |
| Debt | ¥6.64bn | ¥4.82bn | ¥6.52bn | ¥11.57bn | ¥6.41bn | ¥4.01bn | ¥7.59bn | ¥11.66bn |
| Shareholders' equity | ¥29.28bn | ¥28.13bn | ¥27.03bn | ¥27.03bn | ¥25.78bn | ¥25.78bn | ¥24.19bn | ¥24.19bn |
Financial ratios
Data as of 20 Sept 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 35.4% | 35.6% | 33.3% | 34.6% | 34.9% | 34.7% |
| Operating margin | 8.2% | 8.7% | 1.9% | 6.9% | 12.3% | 1.6% |
| Net margin | 7.9% | 6.1% | 1.7% | 4.2% | 8.4% | -0.9% |
| Return on equity | 15.6% | 14.1% | 3.6% | 9.4% | 22.5% | -2.2% |
| Return on assets | 7.4% | 6.9% | 1.6% | 4.4% | 8.0% | -0.8% |
| Free cash flow yield | 4.7% | 9.5% | 0.6% | 2.9% | 12.4% | -1.8% |
| Revenue growth | 2.9% | 21.4% | -5.2% | 16.3% | 28.8% | -1.3% |
| Earnings growth | 33.6% | 324.7% | -60.8% | -41.5% | -1331.1% | -118.4% |
| Current ratio | 2.32x | 2.36x | 2.23x | 2.55x | 2.47x | 3.52x |
| Debt to equity | 0.23x | 0.48x | 0.69x | 0.62x | 1.06x | 1.35x |
| Equity ratio | 47.5% | 48.6% | 44.3% | 46.9% | 35.6% | 35.3% |
| Interest coverage | 33.31x | 43.83x | 10.70x | 38.40x | 75.52x | 8.20x |
| R&D as a share of sales | — | 2.7% | — | — | — | — |
| Buybacks as a share of market value | 0.5% | -0.4% | 4.4% | 3.8% | -15.3% | 0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 5.8% | 12.2% | — |
| Operating income | 12.0% | 56.4% | — |
| Net income | 30.6% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 35.5% | 34.8% | 34.8% | — |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Price to earnings | 15.3 | 11.9 | 34.7 | 17.1 | 14.2 | -212.8 | 23.3 | 35.5 |
| Price to sales | 1.2 | 0.7 | 0.6 | 0.7 | 1.2 | 1.9 | 1.1 | 2.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 4 years. Last went ex-dividend on 29 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Paid in the year | 2.50 | 4.50 | 2.25 | 2.25 |
- 2-for-1 split · 29 Sept 2025
- 2-for-1 split · 29 Sept 2022
- 2-for-1 split · 29 Sept 2021
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.